Target intelligence / Profile preview

Blepharophimosis, epicanthus inversus and ptosis candidate 1 (non-protein coding) (BPESC1)

Target
BPESC1
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

BPESC1 is a long non-coding RNA (lncRNA) gene located in a chromosomal region that has been proposed as a candidate for involvement in blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES), mainly due to structural variants such as deletions affecting the FOXL2 region or surrounding regulatory elements. BPESC1 itself does not encode a known protein, nor is it a recognized receptor, enzyme, or therapeutic target. While it has been referenced in studies of regulatory elements near FOXL2, no direct molecular function or therapeutic relevance has been established. The gene is annotated in multiple databases as a non-coding RNA with no verified molecular activity or disease causality. There are no known drugs or biomarkers associated with this locus. Most functional studies in BPES implicate FOXL2 protein-coding gene, not BPESC1. BPESC1 is not considered a canonical therapeutic target, and its attribution as a disease-associated gene represents likely confusion with more definitively validated protein-coding genes in the same genomic region.

Other names
NCRNA00187Blepharophimosis, epicanthus inversus and ptosis, candidate 1Putative BPES syndrome breakpoint region proteinBPESC1BPES candidate 1non-protein coding RNA 187blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)
02

Biological functions

Unknown; may have regulatory roles, but not experimentally validated
03

Disease associations

May be associated with blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) through structural or regulatory genomic alterations, but not a direct causal gene

Beyond the preview

Go deeper on Blepharophimosis, epicanthus inversus and ptosis candidate 1 (non-protein coding) (BPESC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blepharophimosis, epicanthus inversus and ptosis candidate 1 (non-protein coding) (BPESC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call